Jeff Johnson
Stock Analyst at Baird
(4.58)
# 188
Out of 5,128 analysts
152
Total ratings
54.81%
Success rate
28.19%
Average return
Main Sectors:
Stocks Rated by Jeff Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Upgrades: Outperform | $18 → $30 | $22.71 | +32.10% | 17 | Dec 16, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $117 → $100 | $92.67 | +7.91% | 15 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Outperform | $85 → $98 | $83.90 | +16.81% | 19 | Dec 5, 2025 | |
| ALC Alcon | Maintains: Outperform | $95 → $98 | $81.02 | +20.96% | 11 | Nov 13, 2025 | |
| DXCM DexCom | Maintains: Outperform | $112 → $90 | $70.10 | +28.39% | 15 | Sep 26, 2025 | |
| BBNX Beta Bionics | Maintains: Neutral | $15 → $17 | $31.49 | -46.01% | 2 | Jul 30, 2025 | |
| HSIC Henry Schein | Downgrades: Neutral | $82 → $72 | $78.14 | -7.86% | 10 | Jul 14, 2025 | |
| NVST Envista Holdings | Upgrades: Outperform | $21 → $23 | $22.93 | +0.31% | 10 | May 27, 2025 | |
| SYK Stryker | Maintains: Outperform | $378 → $405 | $367.75 | +10.13% | 11 | Oct 30, 2024 | |
| ALGN Align Technology | Maintains: Outperform | $325 → $276 | $166.81 | +65.46% | 18 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $180 → $238 | $299.17 | -20.45% | 12 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $67 → $70 | $27.69 | +152.80% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $53 → $61 | $15.64 | +290.03% | 4 | Jul 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $78 → $67 | $12.37 | +441.63% | 6 | Feb 18, 2022 |
Tandem Diabetes Care
Dec 16, 2025
Upgrades: Outperform
Price Target: $18 → $30
Current: $22.71
Upside: +32.10%
Zimmer Biomet Holdings
Dec 16, 2025
Downgrades: Neutral
Price Target: $117 → $100
Current: $92.67
Upside: +7.91%
The Cooper Companies
Dec 5, 2025
Maintains: Outperform
Price Target: $85 → $98
Current: $83.90
Upside: +16.81%
Alcon
Nov 13, 2025
Maintains: Outperform
Price Target: $95 → $98
Current: $81.02
Upside: +20.96%
DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112 → $90
Current: $70.10
Upside: +28.39%
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15 → $17
Current: $31.49
Upside: -46.01%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82 → $72
Current: $78.14
Upside: -7.86%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21 → $23
Current: $22.93
Upside: +0.31%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378 → $405
Current: $367.75
Upside: +10.13%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325 → $276
Current: $166.81
Upside: +65.46%
Dec 21, 2023
Upgrades: Outperform
Price Target: $180 → $238
Current: $299.17
Upside: -20.45%
Aug 4, 2023
Maintains: Outperform
Price Target: $67 → $70
Current: $27.69
Upside: +152.80%
Jul 28, 2023
Maintains: Outperform
Price Target: $53 → $61
Current: $15.64
Upside: +290.03%
Feb 18, 2022
Maintains: Outperform
Price Target: $78 → $67
Current: $12.37
Upside: +441.63%